United States of America, ex rel. 3DQA, LLC v. Theken Companies, LLC, Randall Theken, NextStep Arthropedix, LLC, Slice MFG, LLC n/k/a Theken Port Park, LLC

District Court, M.D. Florida·Decided September 15, 2026·No. 2:26-cv-01896·Unknown

Opinion

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA FORT MYERS DIVISION

UNITED STATES OF AMERICA, ex rel. 3DQA, LLC

Relator,

MICHAEL RAPPACH and BOBI LEKIC

Plaintiffs,

v. Case No: 2:26-cv-1896-KCD-NPM

THEKEN COMPANIES, LLC,

Respondent,

RANDALL THEKEN, NEXTSTEP ARTHROPEDIX, LLC, SLICE MFG, LLC n/k/a THEKEN PORT PARK, LLC,

Defendants.

ORDER Relator 3DQA, LLC brings this False Claims Act (“FCA”) suit against the Theken Companies, LLC, Randall Theken, NextStep Arthropedix, LLC, and Slice MFG, LLC (collectively “Defendants”). The complaint accuses Defendants of funneling illegal kickbacks to surgeons under the guise of product development royalties. Michael Rappach and Bobi Lekic, former employees of Defendants, also bring a retaliation claim alleging that Defendants orchestrated false criminal charges for stealing company records.

(Doc. 42.)1 Defendants now move to dismiss the complaint. Their primary arguments are that the first-to-file rule bars the qui tam allegations and the anti-retaliation provision of the FCA does not provide a cause of action for former employees. (Doc. 71.) The Court agrees with both, so the motion is

GRANTED. I. Background Like all FCA cases, the story begins with Defendants defrauding the United States. The scheme is relatively straightforward. The medical device

company Theken—through its subsidiaries NextStep and Slice— manufactured a total hip arthroplasty system used in hip replacement surgeries (“iNSitu System”). They also paid royalty fees to the surgeons who contributed to its development (the “Surgeon Consultants”).

These royalty fees are subject to the Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b), (g), which prohibits any entity from making payments to induce a person to purchase an item that may be bought under a Federal health care plan. To avoid violating the Anti-Kickback Statute (and in turn the FCA),

Defendants used Royalty Agreements with the Surgeon Consultants. (Doc. 42

1 Unless otherwise indicated, all internal quotation marks, citations, and alterations have been omitted in this and subsequent citations. at ¶¶ 45–46, 48.) The agreements were designed to fall within the Anti- Kickback Statute’s personal services safe harbor by setting the Surgeon

Consultants’ compensation based upon their contribution to the iNSitu System before any development began. (Id. ¶¶ 46, 48.) In reality, the compensation was designed to align with each surgeon’s expected order volume of the iNSitu System. And any payments were

contingent upon ordering the product for their own patients. (Id. ¶ 50.) Defendants’ internal sales and royalty data even reflect that once the surgeon reflected a low return on investment, they would “harass” the surgeon and ask them to be “committed to the company and working hard with us every week

on cases and feedback.” (Id. ¶¶ 54–55.) Once Defendants felt as though the surgeons were no longer providing the appropriate return on investment, they stopped the royalty payments altogether. (Id. ¶¶ 53, 59–65.) Apart from that financial arrangement, Defendants’ manufacturing of

the iNSitu System allegedly contained two issues. First, the acetabular cups contained less aluminum than required under Advancing Standards Transforming Markets (“ASTM”) F136. (Id. ¶¶ 68–69.) Second, the iNSitu System did not comply with the tensile strength requirements of ASTM

E8/E8M. (Id. ¶ 70.) Because of the above scheme, 3DQA filed this FCA lawsuit on February 14, 2022, at 2:47 PM. (Doc. 2 at 1.) But they were not the first. Just 18 minutes earlier, a related lawsuit was filed (Doc. 72-3 at 1) based upon the same Royalty Agreements. See United States ex rel. Fries v. NextStep Arthropedix, LLC, No.

2:22-cv-98-KCD-NPM (M.D. Fla. filed Feb. 14, 2022). Once the Department of Justice disclosed the existence of this lawsuit to Defendants, they pegged Rappach and Lokic as the perceived whistleblowers. (Doc. 42 at ¶¶ 83–85.) Within a month of the DOJ’s disclosure—and more than

four years after Rappach and Lekic were no longer employees—Defendants contacted authorities in Ohio to bring criminal charges. (Id. at ¶ 87.) A police report was made, and several months later Rappach and Lekic were indicted for, among other things, stealing documents. (Id. at ¶¶ 87–88.) That criminal

case is ongoing. II. Legal Standard To survive a motion to dismiss, “a complaint must contain sufficient facts, accepted as true, to state a facially plausible claim for relief.” Galette v.

Goodell, No. 23-10896, 2023 WL 7391697, at *3 (11th Cir. Nov. 8, 2023). “A claim is facially plausible if it pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Id. The question here is not whether the plaintiff will ultimately win,

but simply whether the complaint can proceed into discovery. As this stage, we must accept the complaint’s factual allegations as true and construe them in the light most favorable to the plaintiff. Erickson v. Pardus, 551 U.S. 89, 93–94 (2007). That benefit of the doubt, however, has limits. The Court need not accept legal conclusions dressed up as factual

allegations. Bell Atl. Corp v. Twombly, 550 U.S 544, 555 (2007). A pleading that offers nothing more than “labels and conclusions” or a “formulaic recitation of the elements of a cause of action” will not unlock the courthouse doors. Id. In other words, the plaintiff must tell a factual story that makes the

defendant’s liability plausible, not just point a finger and recite the law. See, e.g., Davila v. Delta Air Lines, Inc., 326 F.3d 1183, 1185 (11th Cir. 2003). “We use a two-step process to determine whether a claim survives Rule 12(b)(6) scrutiny.” Caterpillar Fin. Servs. Corp. v. Venequip Mach. Sales Corp.,

147 F.4th 1341, 1346–47 (11th Cir. 2025). First, “we determine what must be plead for each cause of action. . . . Then, we consider the well-pleaded factual allegations . . . to determine whether they plausibly suggest an entitlement to relief.” Id.

III. Discussion a. False Claims Act First, Defendants argue that the first-to-file rule bars Plaintiffs’ FCA claim because the related Fries action alleges the same scheme. (Doc. 71 at 9–

14.) Plaintiffs respond that the first-to-file rule does not apply because its complaint “alerted the government to a broader, more pervasive, and distinct scheme.” (Doc. 90 at 6.) The Court agrees with Defendants. The FCA is clear: “if you ain’t first, you’re last.” Talladega Nights: The Ballad of Ricky Bobby (Columbia Pictures 2006). In more legal terms, “[w]hen

a person brings an action under [the FCA], no person other than the Government may intervene or bring a related action based on the facts underlying the pending action.” 31 U.S.C. § 3730(b)(5). The first-to-file bar eliminates “parasitic plaintiffs who piggyback off the claims of a prior relator,

and [] encourage[s] legitimate relators to file quickly by protecting the spoils of the first to bring a claim.” See Cho ex rel. States v. Surgery Partners, Inc., 30 F.4th 1035, 1040 (11th Cir. 2022). To determine whether qui tam actions are related, the Eleventh Circuit

Free access — add to your briefcase to read the full text and ask questions with AI

United States of America, ex rel. 3DQA, LLC v. Theken Companies, LLC, Randall Theken, NextStep Arthropedix, LLC, Slice MFG, LLC n/k/a Theken Port Park, LLC, (M.D. Fla. 2026).

United States of America, ex rel. 3DQA, LLC v. Theken Companies, LLC, Randall Theken, NextStep Arthropedix, LLC, Slice MFG, LLC n/k/a Theken Port Park, LLC (United States of America, ex rel. 3DQA, LLC v. Theken Companies, LLC, Randall Theken, NextStep Arthropedix, LLC, Slice MFG, LLC n/k/a Theken Port Park, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Boardman Petroleum, Inc. v. Federated Mutual Insurance
135 F.3d 750 (Eleventh Circuit, 1998)
Bryant v. Avado Brands, Inc.
187 F.3d 1271 (Eleventh Circuit, 1999)
Manuel Davila v. Delta Air Lines, Inc.
326 F.3d 1183 (Eleventh Circuit, 2003)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
Hall v. Hall
584 U.S. 59 (Supreme Court, 2018)
Potts v. Ctr. for Excellence in Higher Educ., Inc.
908 F.3d 610 (Tenth Circuit, 2018)
Jamie Nesbitt v. Candler County, Georgia
945 F.3d 1355 (Eleventh Circuit, 2020)
U.S. ex rel. David Felten v. William Beaumont Hosp.
993 F.3d 428 (Sixth Circuit, 2021)
Jose Perez v. Owl, Inc.
110 F.4th 1296 (Eleventh Circuit, 2024)
United States v. John R. Moore, Jr.
115 F.4th 1370 (Eleventh Circuit, 2024)